In the first half of the year, the export volume of pharmaceutical products in Yinchuan City, Ningxia, increased by 12.5%.

According to Yinchuan customs statistics, in the first half of the region's pharmaceutical exports of 870 million yuan, an increase of 12.5%. In June, china's pharmaceutical exports reached 150 million yuan, an increase of 33.2%, from a monthly export point of view, except for the decline in pharmaceutical exports in March, the remaining five months of export growth., the main characteristics of pharmaceutical exports in our region
(i) are general trade exports, private enterprises as the main export enterprises. In the first half of the year, the export of pharmaceutical products in our region by general trade was 870 million yuan, an increase of 12.5%. Private enterprises exported 500 million yuan, down 0.2%, while state-owned enterprises exported 370 million yuan, an increase of 34.7%.
(ii) India, the European Union and Latin America are the top three trading partners. In the first half of the year, our region's exports of pharmaceutical products to India increased by 1.8% to 170 million yuan, exports to the European Union increased by 35% to 190 million yuan, exports to Latin America increased by 21%, exports to ASEAN increased by 11.6% to 140 million yuan, and exports to the United States increased by 26%. Exports to the above-mentioned trading partners amounted to 740 million yuan, accounting for 85% of the value of pharmaceutical exports in our region during the same period.
(iii) antimicrobial and vitamin exports increased. In the first half of the year, the export of antibiotics in our region was 620 million yuan, an increase of 35.4%, accounting for 71.3% of the total value of pharmaceutical exports in our region during the same period; Yuan, an increase of 2.1 times, vitamin B12 exports of 110 million yuan, an increase of 19.4%, 2, the main reason for the growth of pharmaceutical exports in our region
(1) pharmaceutical enterprises to improve international competitiveness, export market demand is good. Pharmaceutical enterprises through participation in trade associations to organize overseas exhibitors, further develop the international market, complete the European Union, the United States and other pharmaceutical export markets of pharmaceutical products access qualification, drug replacement, and further improve the share of exports. India and the European Union have a large demand for imported rigidity of Ningxia Achimycin API.
(ii) The increase in the price of vitamin exports has led to an increase in pharmaceutical exports. In the first half of the year, the export volume of vitamin B12 and vitamin C in our region increased by 66% and 9.6% respectively, while the average export price increased by 89.5% and 9% respectively, driving the export of pharmaceutical products in our region to increase by 13%. Among antibiotics, the export of lincomycin increased by 66.5%, the export of tylutin salt increased by 11.3%, and the export of the remaining antibiotics decreased.
The world bank predicts that the economies of India, Argentina and Brazil will continue to grow in 2017, and the global API market is expected to grow at a compound rate of 6.6 percent between 2015 and 2020, according to a PMR study. In the international environment of expanding global demand for pharmaceuticals and economic recovery in the pharmaceutical export market, the export of pharmaceutical products in our region is expected to grow further. To this end, the proposal: First, to increase the policy tilt of pharmaceutical production enterprises, guide pharmaceutical enterprises to complete international market access certification, joint trade associations to organize pharmaceutical enterprises to participate abroad, expand the visibility of pharmaceutical enterprises in our region. Second, to encourage pharmaceutical enterprises in our region from the production of raw materials to pharmaceutical production transformation, replacement products, expand the high-end pharmaceutical market. Third, guide enterprises to strengthen the international trade protection measures and new technical standards, to achieve diversification of export markets, reduce exchange rates, trade protection and other risks. (Ningxia People's Government website)